Click on the links below to view active BrIDGs projects:
- BPN14770 for Treatment of Fragile X Syndrome
- Development of Drinabant for Treatment of Acute Cannabinoid Overdose
- Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury
- Evaluation of ACT1 to Treat Diabetic Keratopathy
- IND-Enabling Preclinical Studies of 2DG for Treatment of Epilepsy
- Peripheral CB1 Receptor Antagonist for Therapeutic Use in Metabolic Syndrome
- Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma
- Studies of Tumor-Penetrating Microparticles for Pancreatic Cancer
- Targeted Bone Regeneration via Activation of Resident Stem Cells